Arkolith/Insider Trading/HRTX/Form 4

Rosen David Efraim

10% OwnerHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Aug 12, 2025
Net Buying
Open-Market Buys
$3.6M
Open-Market Sells
$0
Net Open-Market Flow
$3.6M
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2025Buy(P)2.4M$1.50$3.6M29.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2025Buy(P)95K$33250000.00$3.1T95K
Aug 8, 2025Buy(P)0$15.00$0—

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-003535) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML